fbpx
Call our law firm today! Consult with the partners for FREE. 800-734-9445

Former VA Doctor Charged in the Deaths of 3 Patients

By |2019-08-21T12:40:11+00:00August 21st, 2019|Local News, Medical Malpractice, Veterans Hospitals|

LITTLE ROCK, Ark. POSTED 2:19 PM, AUGUST 20, 2019, BY ASSOCIATED PRESS, UPDATED AT 06:43PM, AUGUST 20, 2019 Dr. Robert Morris Levy, a pathologist fired from an Arkansas veterans hospital was charged Tuesday August 20th with involuntary manslaughter in the deaths of three patients who authorities say he misdiagnosed and whose records he later altered to conceal [...]

FDA orders manufacturers of surgical mesh intended to treat pelvic organ prolapse, to stop distribution immediately

By |2019-05-09T13:29:26+00:00May 7th, 2019|Defective Medical Equipment, Defective Products, Medical Malpractice, Recalls, Uncategorized|

On April 16, 2019, the FDA ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop selling and distributing their products immediately. The FDA has determined that the manufacturers, Boston Scientific and Coloplast, have not demonstrated reasonable assurance of safety and effectiveness for these devices, which is the premarket standard [...]

Hundreds Died Due to Medical Misconduct in NYC Hospitals

By |2019-03-13T14:51:42+00:00March 14th, 2019|Local News, Medical Malpractice, Negligence|

 468 people were killed  in New York City’s 11 public hospitals in the past five years, due to medical misconduct. The vast majority of wrongful-death cases filed against the Health and Hospital Corp. system in the last five years — 88 percent — remain open, leaving hundreds of bereaved families in financial limbo for years [...]

Recall Changes on Valsartan, Losartan and Irbesartan

By |2019-05-09T13:30:55+00:00March 1st, 2019|Failure To Diagnose, Local News, Medical Malpractice, Medical Recalls, Uncategorized|

FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan IMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled. Manufacturers are recalling medications containing amlodipine in combination with valsartan or losartan, and medications containing hydrochlorothiazide HCTZ in combination with valsartan or losartan. […]

If You Have Gout and Take This Medicine – You Need to Know This

By |2019-02-22T16:57:11+00:00February 22nd, 2019|Failure To Diagnose A Heart Attack, Failure To Properly Read X-rays And Mammograms, Medication Errors, Press Releases, Recalls|

FDA has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol. This conclusion is based on our in-depth review of results from a safety clinical trial that found an increased risk of heart-related death and death from all causes with Uloric.

FDA Warns Taking These Antibiotics Could Rupture Aorta

By |2019-01-08T21:20:10+00:00January 8th, 2019|Medical Malpractice, Medical Recalls, Negligence|

A U.S. Food and Drug Administration (FDA) review found that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the main artery of the body, called the aorta. These tears, called aortic dissections, or ruptures of an aortic aneurysm can lead to dangerous bleeding or even death.